CM
AUPH icon

Caption Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Caption Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,330
Closed -$61.4K – 1566
2025
Q3 		$47.8K Sell
4,330
-159,214
-97% -$1.74M ﹤0.01% 1563
2025
Q2 		$1.39M Buy
163,544
+25,392
+18% +$204K 0.02% 842
2025
Q1 		$1.11M Buy
138,152
+111,482
+418% +$903K 0.01% 878
2024
Q4 		$239K Buy
+26,670
New +$218K ﹤0.01% 1244
2024
Q3 		– Sell
-6,076
Closed -$37.7K – 1269
2024
Q2 		$34.7K Buy
+6,076
New +$32K ﹤0.01% 1075
2024
Q1 		– Sell
-114,200
Closed -$1.03M – 1197
2023
Q4 		$1.03M Buy
114,200
+81,000
+244% +$667K 0.01% 799
2023
Q3 		$258K Buy
+33,200
New +$325K ﹤0.01% 1061
2023
Q1 		– Sell
-21,900
Closed -$193K – 1084
2022
Q4 		$94.6K Sell
21,900
-36,100
-62% -$209K ﹤0.01% 1135
2022
Q3 		$436K Buy
58,000
+43,678
+305% +$378K 0.01% 1096
2022
Q2 		$144K Sell
14,322
-31,967
-69% -$357K ﹤0.01% 1266
2022
Q1 		$574K Sell
46,289
-27,166
-37% -$420K 0.01% 1113
2021
Q4 		$1.68M Buy
+73,455
New +$1.74M 0.02% 849
2021
Q2 		– Sell
-19,500
Closed -$248K – 1286
2021
Q1 		$253K Sell
19,500
-95,500
-83% -$1.39M 0.01% 893
2020
Q4 		$1.59M Hold
115,000
– – 0.04% 499
2020
Q3 		$1.69M Sell
115,000
-32,657
-22% -$473K 0.04% 488
2020
Q2 		$2.4M Buy
147,657
+113,457
+332% +$1.82M 0.08% 331
2020
Q1 		$497K Buy
34,200
+9,200
+37% +$162K 0.03% 544
2019
Q4 		$506K Buy
+25,000
New +$230K 0.02% 623

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caption Management's AUPH Position: Q4 2025 in Review

Caption Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 4,330 shares — an estimated $61.4K sold.

Caption Management first reported a position in AUPH in Q4 2019 and held it in 18 quarters. The position peaked at $2.4M in Q2 2020. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • Caption Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 4,330 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $61.4K.
  • Caption Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 18 quarters.
  • Caption Management's Aurinia Pharmaceuticals position peaked at $2.4M in Q2 2020.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.